WASHINGTON -- Federal health officials approved sale of the world's first contraceptive patch yesterday, giving women an option considered as safe and effective as the pill but easier for some to use.

It’s should be common knowledge that the Johnson & Johnson (J&J) Ortho-Evra birth-control patch has more risks than the birth control pill (it’s on the label) — because it exposes women to higher ...

A contraceptive patch has been approved for use across Europe. Evra, a smooth beige patch is applied to the skin. A patch lasts for a week at a time and is used for three consecutive weeks, with the ...

The patch supplies norelgestromin and ethinyl estradiol to the bloodstream through the skin. Has any evidence of genital swelling been documented with the use of the patch when placed inappropriately?